ALHC stock forecast, quote, news & analysis
Alignment Healthcare Inc is a next-generation, consumer-centric platform that is revolutionizing the healthcare experience for seniors through Medicare Advantage plans... Show more
Why Is Alignment Healthcare (ALHC) Stock Down -11.18% Today?
Key Takeaways
- Shares of ALHC plunged 11.18% to $20.02 from the previous close of $22.54.
- The selloff followed first-quarter 2026 earnings, where revenue beat estimates at $1.235 billion but EPS missed at $0.05 versus $0.09 expected.
- Trading volume surged above average, reflecting heightened investor reaction to the results.
- Broader healthcare sector context showed mixed performance amid ongoing Medicare Advantage scrutiny.
- Investors are watching Q2 guidance, membership growth trends, and the upcoming BofA Securities Health Care Conference presentation on May 13.
Opening Summary
Alignment Healthcare, Inc. (ALHC), a consumer-centric healthcare platform delivering Medicare Advantage plans to seniors, saw its shares drop sharply in Thursday's trading session. The stock fell 11.18% to a latest price of $20.02 from the prior session's closing price of $22.54. Markets attributed the decline primarily to a post-earnings reaction, despite strong revenue growth in the first quarter.
Earnings Results
Alignment Healthcare released its Q1 2026 results after the market close on Wednesday, reporting revenue of $1.235 billion, up 33.3% year-over-year and surpassing analyst expectations. The company highlighted robust membership growth of 31% and progress in margin expansion through operational efficiencies and AI-driven workflows. However, adjusted EPS came in at $0.05, missing the consensus estimate of $0.09. This shortfall triggered profit-taking and selling pressure, overshadowing the positive top-line performance and raised full-year outlook for adjusted EBITDA between $138 million and $163 million.
Market Context and Trading Activity
Trading volume spiked significantly, exceeding 5 million shares compared to the average daily volume of around 3 million, indicating intense market interest in the earnings print. The move diverged from broader indices, which traded mixed, while healthcare peers in the Medicare Advantage space showed varied responses. Technically, the stock breached its recent support near $21.50, accelerating the downside momentum amid elevated volatility post-earnings.
Trending AI Robots
Tickeron’s Trending AI Robots page showcases the platform’s top-performing AI-driven trading bots under prevailing market conditions. Tickeron offers hundreds of such bots, each employing distinct strategies like trend-following, mean reversion, or momentum trading across various timeframes and performance metrics. These bots scan and trade thousands of tickers, including healthcare names like ALHC, adapting dynamically to volatility from events such as earnings releases. The curated selection highlights only the strongest current performers, providing investors with data-backed insights into algorithmic opportunities. Explore the page to identify bots aligning with your trading style and market outlook.
What Comes Next for ALHC
Alignment Healthcare affirmed Q2 revenue guidance of $1.3 billion to $1.32 billion and adjusted EBITDA of $50 million to $60 million, with full-year membership growth on track. The company will present at the BofA Securities Health Care Conference on May 13, where executives may provide further color on strategic initiatives. Analysts maintain a consensus "Buy" rating with price targets around $24-$25, citing long-term potential in Medicare Advantage expansion. Key risks include regulatory changes in healthcare reimbursements, competitive pressures, and execution on cost controls amid sector headwinds.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
ALHC's MACD Histogram just turned positive
The Moving Average Convergence Divergence (MACD) for ALHC turned positive on June 08, 2026. Looking at past instances where ALHC's MACD turned positive, the stock continued to rise in of 41 cases over the following month. The odds of a continued upward trend are .
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on June 09, 2026. You may want to consider a long position or call options on ALHC as a result. In of 81 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
ALHC moved above its 50-day moving average on June 09, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for ALHC crossed bullishly above the 50-day moving average on June 17, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ALHC advanced for three days, in of 300 cases, the price rose further within the following month. The odds of a continued upward trend are .
Bearish Trend Analysis
The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The 50-day moving average for ALHC moved below the 200-day moving average on June 17, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ALHC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
ALHC broke above its upper Bollinger Band on June 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for ALHC entered a downward trend on June 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. ALHC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: ALHC's P/B Ratio (21.834) is very high in comparison to the industry average of (4.965). ALHC's P/E Ratio (218.550) is considerably higher than the industry average of (48.785). ALHC's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (1.279). ALHC's Dividend Yield (0.000) is considerably lower than the industry average of (0.020). P/S Ratio (1.042) is also within normal values, averaging (0.646).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ALHC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry ManagedHealthCare